Skip to main content

Chr. Hansen Holding A/S (CHR.CO)

Nasdaq Copenhagen Basic Materials Chemicals - SpecialtyView data quality →
44.7Fair

ValueMarkers Composite Index

Top 15%#38,040 of 44,707

DCF data not available

Piotroski
2/9
Weak
Beneish
-
Altman
-
DCF Value
-
N/A
ROIC
9.2%
Adequate
P/E
42.8
Growth
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Chr. Hansen Holding A/S (CHR.CO) — VMCI valuation read

Across 120 indicators, Chr. Hansen Holding A/S (CHR.CO) lands at VMCI 45/100. The Basic Materials sector median is 50, so the 5-point below-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on CHR.CO in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, CHR.CO trades at 25.0x earnings, 39% above the Basic Materials median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 9.0% trails the Basic Materials median (10.0%) by 1.0pp. On Risk, net debt to EBITDA of -2.1x leaves covenant headroom for CHR.CO on the trailing balance sheet.

CHR.CO fell 1.0% over the trailing 7 days, with a +2.5% read on a 30-day basis.

Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. The company operates through Food Cultures & Enzymes, and Health & Nutrition segments. The Food Cultures & Enzymes segment produces and sells various cultures, enzymes, and probiotic products that determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of various consumer products in the food industry, primarily in the dairy industry. The Health & Nutrition segment produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. It has a strategic collaboration with UPL Ltd. to develop and commercialize microbial-based bio solutions for sustainable agriculture. The company was founded in 1843 and is headquartered in Hørsholm, Denmark.

CEO: Mauricio Graber3,834 employeesDKwww.chr-hansen.com

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in CHR.CO’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.